Global Digital Therapeutics Market Report 2021: Digital Therapeutics Continue to Attract Venture Capital Investments - Forecasts to 2027

Dublin, July 19, 2021 (GLOBE NEWSWIRE) -- The "Digital Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Digital Therapeutics Market to Reach US$1.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Digital Therapeutics estimated at US$347.2 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 24.6% over the period 2020-2027.

Preventive, one of the segments analyzed in the report, is projected to grow at a 22.7% CAGR to reach US$421.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment/Care segment is readjusted to a revised 25.3% CAGR for the next 7-year period. This segment currently accounts for a 71% share of the global Digital Therapeutics market.

The U.S. Accounts for Over 29.9% of Global Market Size in 2020, While China is Forecast to Grow at a 24.1% CAGR for the Period of 2020-2027

The Digital Therapeutics market in the U.S. is estimated at US$103.8 Million in the year 2020. The country currently accounts for a 29.9% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$282.8 Million in the year 2027 trailing a CAGR of 24.1% through 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.6% and 21.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 17.5% CAGR while Rest of European market (as defined in the study) will reach US$282.8 Million by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• Influencer Market Insights

• Impact of Covid-19 and a Looming Global Recession

• Digital Therapeutics: An Introduction

• Outlook

• Leading Markets

• Factors Impeding Growth

• Canary Health, Inc. (USA)

• Dthera Sciences (USA)

• Fitbit Health Solutions (USA

• Livongo Health, Inc. (USA)

• Medtronic, Plc (Ireland)

• Omada Health, Inc. (USA)

• Propeller Health (USA)

• Pear Therapeutics, Inc. (USA)

• Proteus Digital Health, Inc. (USA)

• WellDoc, Inc. (USA)

• Digital Therapeutics Continue to Attract Venture Capital Investments

• Startups Flock the Digital Therapeutics Market

• Select Digital Therapeutics Startups

• Digital Health Unicorn Startups

• Pipeline Products Drive Growth Prospects

• A Snapshot of Select DTx Pipeline Products

• Pharma Majors Foray into Uncharted Territory

• Pharmaceutical Companies Team Up with Payers to Seek Reimbursement

• Growing Focus on Preventative Healthcare Widens Growth Opportunities

• Overcoming the Stigma of Mental Health through Digital Therapeutics

• Global Number of People Suffering from Mental Disorders (In Million)

• Growing Prevalence of Chronic Diseases to Boost Market Growth

• Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025

• Digital Therapeutics in Oncology

• Proliferation of Smart Devices Bodes Well for Market Growth

• Growing Focus on Reducing Healthcare Costs Bolsters Market Growth

• Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver

• World Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

• World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027

• World Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

• World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

• World Current & Future Analysis for Treatment/Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

• World 7-Year Perspective for Treatment/Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

• World Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

• World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

• World Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

• World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 56

For more information about this report visit https://www.researchandmarkets.com/r/mxz6j5

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900